Citigroup Inc Karyopharm Therapeutics Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Citigroup Inc holds 105,693 shares of KPTI stock, worth $69,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,693

Previous 162,027 34.77%

Holding current value

$69,757

Previous $140,000 37.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.7 - $1.06 $39,433 - $59,714	-56,334 Reduced 34.77%	105,693 $87,000
Q2 2024 Aug 12, 2024	BUY	$0.87 - $1.58 $124,499 - $226,102	143,103 Added 756.2%	162,027 $140,000
Q1 2024 May 10, 2024	BUY	$0.72 - $1.66 $1,794 - $4,136	2,492 Added 15.17%	18,924 $28,000
Q4 2023 Feb 09, 2024	BUY	$0.68 - $1.31 $10,082 - $19,423	14,827 Added 923.8%	16,432 $14,000
Q3 2023 Nov 09, 2023	SELL	$1.14 - $1.81 $41,770 - $66,320	-36,641 Reduced 95.8%	1,605 $2,000
Q2 2023 Aug 10, 2023	SELL	$1.79 - $4.59 $1.24 Million - $3.18 Million	-691,781 Reduced 94.76%	38,246 $68,000
Q1 2023 May 11, 2023	BUY	$2.84 - $3.92 $628,872 - $868,021	221,434 Added 43.54%	730,027 $2.84 Million
Q4 2022 Feb 09, 2023	SELL	$2.48 - $5.93 $245,031 - $585,901	-98,803 Reduced 16.27%	508,593 $1.73 Million
Q3 2022 Nov 10, 2022	BUY	$4.08 - $5.82 $564,578 - $805,354	138,377 Added 29.5%	607,396 $3.32 Million
Q2 2022 Aug 10, 2022	BUY	$4.15 - $8.37 $1.42 Million - $2.86 Million	341,239 Added 267.05%	469,019 $2.12 Million
Q1 2022 May 12, 2022	SELL	$5.91 - $14.38 $1.04 Million - $2.54 Million	-176,318 Reduced 57.98%	127,780 $942,000
Q4 2021 Feb 10, 2022	BUY	$5.21 - $8.61 $317,028 - $523,918	60,850 Added 25.02%	304,098 $1.96 Million
Q3 2021 Nov 10, 2021	BUY	$4.45 - $10.63 $1.08 Million - $2.59 Million	243,248 New	243,248 $1.42 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $52.7M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account